Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up".
File(s)Reply letter woscops 2018.doc (35.5 KB)
Accepted version
Author(s)
Vallejo-Vaz, AJ
Packard, Chris J
Ray, kausik
Type
Journal Article
Date Issued
2018-05-29
Date Acceptance
2018-02-06
Citation
Circulation, 2018, 22 (137), pp.2419-2420
ISSN
0009-7322
Publisher
American Heart Association
Start Page
2419
End Page
2420
Journal / Book Title
Circulation
Volume
22
Issue
137
Copyright Statement
© 2018 American Heart Association, Inc.
Sponsor
Sanofi Aventis
Grant Number
UKME-15-00020
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Peripheral Vascular Disease
Cardiovascular System & Cardiology
COHORT
1103 Clinical Sciences
1102 Cardiovascular Medicine And Haematology
1117 Public Health And Health Services
Cardiovascular System & Hematology
Publication Status
Published
Date Publish Online
2018-05-29